Financial Conflicts of Interest Checklist 2010 for clinical research studies
暂无分享,去创建一个
Sunila R. Kalkar | D. Moher | P. Rochon | D. Streiner | A. Gruneir | A. Chan | M. Sekeres | J. Lexchin | J. Hoey | L. Ferris | Wei Wu | N. Taback | J. Maskalyk | J. Gold | Marleen Van Laethem
[1] Robert W. Matthews,et al. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication , 2010, Journal of pharmacology & pharmacotherapeutics.
[2] D. Moher,et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. , 2010, Obstetrics and gynecology.
[3] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[4] D. Moher,et al. Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.
[5] Ana Marusic,et al. Uniform format for disclosure of competing interests in ICMJE journals. , 2010, JAMA.
[6] Elizabeth Wager,et al. How to handle authorship disputes: a guide for new researchers , 2009, Science Editor and Publisher.
[7] J. Ioannidis,et al. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.
[8] B. Williams-Jones,et al. Conflict of Interest Policies at Canadian Universities: Clarity and Content , 2008 .
[9] E. Campbell,et al. Responses of medical schools to institutional conflicts of interest. , 2008, JAMA.
[10] J. PérezMartín,et al. [International Committee of Medical Journal Editors]. , 2008, Revista alergia Mexico.
[11] Ana Marusic,et al. Clinical trial registration: looking back and moving ahead , 2007, The Lancet.
[12] J. Kimmelman. Inventors as Investigators: The Ethics of Patents in Clinical Trials , 2007, Academic medicine : journal of the Association of American Medical Colleges.
[13] R. Fletcher. Ghost writing initiated by commercial companies , 2005, Journal of General Internal Medicine.
[14] A. Hrõbjartsson,et al. Constraints on publication rights in industry-initiated clinical trials. , 2006, JAMA.
[15] Ermenegyldo Munhoz Junior. Requisitos uniformes para manuscritos submetidos a periódicos biomédicos: escrevendo e editando para publicações biomédicas , 2006 .
[16] R. Steinbrook. Gag clauses in clinical-trial agreements. , 2005, The New England journal of medicine.
[17] David M Studdert,et al. Academic medical centers' standards for clinical-trial agreements with industry. , 2005, The New England journal of medicine.
[18] A. Petryna. Ethical variability: Drug development and globalizing clinical trials , 2005 .
[19] G. Loewenstein,et al. A social science perspective on gifts to physicians from industry. , 2003, JAMA.
[20] C. Gross,et al. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.
[21] C. Naylor. Early Toronto experience with new standards for industry-sponsored clinical research: a progress report. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[22] R. Horton,et al. Sponsorship, authorship and accountability. , 2001, Lakartidningen.
[23] R. Horton,et al. Sponsorship, authorship and accountability. , 2001, The Medical journal of Australia.
[24] T. Bodenheimer,et al. Uneasy alliance--clinical investigators and the pharmaceutical industry. , 2000, The New England journal of medicine.
[25] D Blumenthal,et al. Looking a gift horse in the mouth: corporate gifts supporting life sciences research. , 1998, JAMA.
[26] A. Vickers,et al. Do certain countries produce only positive results? A systematic review of controlled trials. , 1998, Controlled clinical trials.
[27] D. Rennie,et al. When authorship fails. A proposal to make contributors accountable. , 1997, JAMA.
[28] D F Thompson,et al. Understanding financial conflicts of interest. , 1993, The New England journal of medicine.
[29] W. Raub. From the National Institutes of Health. , 1990, JAMA.
[30] The National Academy of Sciences , 1928, Science.